These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Reynolds JL, Ignatowski TA, Sud R, Spengler RN. Neuroscience; 2005 Dec; 133(2):519-31. PubMed ID: 15878644 [Abstract] [Full Text] [Related]
7. Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test. Lapiz MD, Bondi CO, Morilak DA. Neuropsychopharmacology; 2007 May; 32(5):1000-10. PubMed ID: 17077810 [Abstract] [Full Text] [Related]
8. Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study. Mateo Y, Fernández-Pastor B, Meana JJ. Br J Pharmacol; 2001 Aug; 133(8):1362-70. PubMed ID: 11498523 [Abstract] [Full Text] [Related]
9. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade. Valentini V, Cacciapaglia F, Frau R, Di Chiara G. J Neurochem; 2006 Jul; 98(1):113-21. PubMed ID: 16805801 [Abstract] [Full Text] [Related]
10. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. Lacroix D, Blier P, Curet O, de Montigny C. J Pharmacol Exp Ther; 1991 Jun; 257(3):1081-90. PubMed ID: 1646320 [Abstract] [Full Text] [Related]
11. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Lapiz MD, Morilak DA. Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081 [Abstract] [Full Text] [Related]
12. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Devoto P, Flore G, Pira L, Diana M, Gessa GL. Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641 [Abstract] [Full Text] [Related]
14. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Devoto P, Flore G, Pani L, Gessa GL. Mol Psychiatry; 2001 Nov 23; 6(6):657-64. PubMed ID: 11673793 [Abstract] [Full Text] [Related]
16. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Pan WH, Yang SY, Lin SK. Synapse; 2004 Jul 23; 53(1):44-52. PubMed ID: 15150740 [Abstract] [Full Text] [Related]
18. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. J Neurochem; 1995 Jul 23; 65(1):111-6. PubMed ID: 7790854 [Abstract] [Full Text] [Related]
19. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Invernizzi RW, Garattini S. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug 23; 28(5):819-27. PubMed ID: 15363606 [Abstract] [Full Text] [Related]
20. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo. Esteban S, Lladó J, Sastre-Coll A, García-Sevilla JA. Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug 23; 360(2):135-43. PubMed ID: 10494882 [Abstract] [Full Text] [Related] Page: [Next] [New Search]